Oncology Pharmacy News

Project PINK BLUE aims to strengthening the capacity of the Nigerian oncology pharmacy workforce through training in partnership with Fulbright Specialist Program and U.S. Mission in Nigeria.

 

AstraZeneca has developed a scientific exchange forum for clinical pharmacists across the Gulf, through an initiative that aims to educate pharmacists on oncology recent trends and international standards, and ISOPP has been invited to participate. 

 

The Saudi Oncology Pharmacy Assembly (SOPA) is hosting ISOPP’s first ever Saudi Arabia Regional Oncology Pharmacy Conference, scheduled to take place on November 4-6, 2021 as a hybrid event in Riyadh, Saudi Arabia.

 

Submitted by Lynne Nakashima, Senior Director, Provincial Pharmacy, BC Cancer

Due to the ongoing concerns with the COVID-19 pandemic, CAPhO was forced to hold our annual national oncology conference, the CAPhO Conference virtually this year.  It was held June 4-6, 2021 and coincided with CAPhO's 25th Anniversary!

 

By Hisanaga Nomura, Deputy Manager, Japan Agency for Medical Research and Development

In this report, we published our research regarding occupational exposure to hazardous drugs.1

 

By Lisa Holle, PharmD, BCOP, FHOPA, FISOPP

Together, we can fight cancer anywhere. That was the motto of the 17th Annual HOPA conference held April 13-17, 2021. Due to ongoing COVID-19 pandemic, the annual meeting was held virtually for the first time, but that didn’t slow down the educational offerings or the attendance.

 

A position statement to describe the roles of oncology pharmacists and technicians in cancer patient care, created by ISOPP’s Credentialing, Specialization, Scope of Practice Task Force, is now published in the Journal of Oncology Pharmacy Practice (JOPP). 

 

We are ISOPP, was created by ISOPP’s volunteer leadership in support and celebration of this year's World Cancer Day's theme - ‘I Am and I Will', which is all about you and your commitment to act.

 

Watch for the launch of ISOPP’s virtual education program on Oncology Pharmacotherapy and Applications of Biosimilars in 2021; made possible through an educational grant from Pfizer.